Free Trial

IDEXX Laboratories (IDXX) SEC Filings & 10K Form

IDEXX Laboratories logo
$417.66 -5.94 (-1.40%)
Closing price 03/25/2025 04:00 PM Eastern
Extended Trading
$423.50 +5.84 (+1.40%)
As of 07:54 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent IDEXX Laboratories SEC Filings

DateFilerForm TypeView
03/10/2025
6:12 PM
Emerson Andrew (Reporting)
IDEXX Laboratories (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
02/21/2025
7:28 AM
IDEXX Laboratories (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/18/2025
8:42 PM
Erickson Michael G (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:42 PM
FENNELL GEORGE (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:43 PM
Hunt Nimrata (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:43 PM
IDEXX Laboratories (Issuer)
Johnson Michael Perkins (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:43 PM
IDEXX Laboratories (Issuer)
Lane Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:43 PM
IDEXX Laboratories (Issuer)
MAZELSKY JONATHAN JAY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:43 PM
IDEXX Laboratories (Issuer)
Schreck Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:43 PM
IDEXX Laboratories (Issuer)
Smith Martin Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:44 PM
IDEXX Laboratories (Issuer)
Underberg Sharon E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
8:44 PM
IDEXX Laboratories (Issuer)
MCKEON BRIAN P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:52 PM
FENNELL GEORGE (Reporting)
IDEXX Laboratories (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/07/2025
3:08 PM
IDEXX Laboratories (Subject)
SZOSTAK M ANNE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
5:30 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
4:00 PM
Erickson Michael G (Reporting)
IDEXX Laboratories (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
12/09/2024
6:32 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2024
4:00 PM
IDEXX Laboratories (Issuer)
Vandebroek Sophie V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
3:36 PM
IDEXX Laboratories (Subject)
Vandebroek Sophie V. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
6:32 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
2:48 PM
IDEXX Laboratories (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/12/2024
6:30 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
10:47 AM
IDEXX Laboratories (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/31/2024
3:14 PM
IDEXX Laboratories (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
12:23 PM
IDEXX Laboratories (Filer)
Form 8-K/A
10/31/2024
5:30 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
3:18 PM
IDEXX Laboratories (Issuer)
SZOSTAK M ANNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
3:20 PM
AYERS JONATHAN W (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2024
3:36 PM
IDEXX Laboratories (Subject)
SZOSTAK M ANNE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
7:20 PM
IDEXX Laboratories (Issuer)
Schreck Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:03 PM
IDEXX Laboratories (Issuer)
Smith Martin Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
5:30 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2024
3:00 PM
IDEXX Laboratories (Filer)
Form SD
Specialized Disclosure Report  
05/17/2024
2:49 PM
Claflin Bruce L. (Reporting)
IDEXX Laboratories (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2024
6:00 PM
AYERS JONATHAN W (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:00 PM
Britt Irene Chang (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:00 PM
Claflin Bruce L. (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:01 PM
COLLINS Asha (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:01 PM
ESSIG STUART (Reporting)
IDEXX Laboratories (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:01 PM
IDEXX Laboratories (Issuer)
JUNIUS DANIEL M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:02 PM
IDEXX Laboratories (Issuer)
Kingsley Lawrence D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Here’s Why Tesla Insiders are Dumping Shares (Ad)

Tesla has been on a losing streak ever since Elon Musk first visited the White House in early 2025. Our research indicates investors are waking up to the fact that Tesla is no longer Musk's #1 priority. His real goal is political power - and his private AI firm xAI.

But we found a "backdoor" way to get exposure - right from your brokerage account. Click here for th
05/08/2024
6:02 PM
IDEXX Laboratories (Issuer)
SAMAD SAM (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:02 PM
IDEXX Laboratories (Issuer)
SZOSTAK M ANNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2024
6:02 PM
IDEXX Laboratories (Issuer)
Vandebroek Sophie V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
5:30 AM
IDEXX Laboratories (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:IDXX) was last updated on 3/26/2025 by MarketBeat.com Staff
From Our Partners